重视直立性低血压的诊断与处理

doi:10.11817/j.issn.1673-9248.2024.05.001

中华脑血管病杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 403 -405. doi: 10.11817/j.issn.1673-9248.2024.05.001

述评

重视直立性低血压的诊断与处理

刘文玲¹^,^†(

)

1.100044 北京大学人民医院心血管内科

收稿日期:2024-07-11 出版日期:2024-10-01
通信作者: 刘文玲

Emphasizing to the diagnosis and treatment of orthostatic hypotension

Wenling Liu¹^,^†()

1.Department of Cardiovascular Medicine， Peking University People's Hospital， Beijing 100044， China

Received:2024-07-11 Published:2024-10-01
Corresponding author: Wenling Liu

全文 ( ) 下载PDF ( ) 导出引用

直立性低血压（OH），即从卧位到直立位时血压下降，严重时导致晕厥，是一种常见的心血管病症，在老年人和体弱多病的患者中非常常见，由多种神经或非神经疾病引起或促发。其临床意义日益显著，是导致患者生活质量受损和潜在的不良结果的原因，包括冠状动脉疾病、心力衰竭、中风、认知功能障碍和病死率增加。因此，应引起临床医师对OH 的高度重视。处理OH 的目的是改善生活质量和减轻症状，而不是使血压正常化。非药物措施是治疗成功的关键。

关键词: 直立性低血压, 晕厥, 不良结局

Orthostatic hypotension （OH） is a condition characterized by a drop in blood pressure upon standing from a reclining position， which can lead to syncope in severe cases. It is a prevalent cardiovascular issue，particularly affecting the elderly and those with compromised health， and can be triggered or exacerbated by a multitude of neurological and non-neurological disorders. Its clinical significance is increasingly apparent and is the cause of impaired quality of life and potentially adverse outcomes， including coronary artery disease， heart failure，stroke， cognitive dysfunction， and increased mortality. Given its impact， clinicians must prioritize its management.The goal of managing orthostatic hypotension is to improve quality of life and alleviate symptoms， rather than simply normalizing blood pressure. Non-pharmacological interventions are the key to successful treatment.

Key words: Orthostatic hypotension, Syncope, Adverse outcome

1	Juraschek SP， Cortez MM， Flack JM， et al. Orthostatic hypotension in adults with hypertension: a scientific statement from the American Heart Association ［J］. Hypertension， 2024， 81（3）: e16-e30.
2	李贯绯，张逊娟，庞猛，等. 社区中老年人群慢性直立不耐受综合征患病率及影响因素的分析［J］. 中华全科医学， 2023， 21（7）: 1184-1187， 1196.
3	韦晓洁，肖佳佳，李静，等. 老年卧位高血压患者体位性低血压发生情况与营养状况的相关性［J］. 现代医学， 2023， 51（7）: 895-899.
4	Ricci F， Fedorowski A， Radico F， et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies ［J］. Eur Heart J， 2015， 36（25）: 1609-1617.
5	Mol A， Bui Hoang PTS， Sharmin S， et al. Orthostatic hypotension and falls in older adults: a systematic review and meta-analysis ［J］. J Am Med Dir Assoc， 2019， 20（5）: 589-597.
6	Palma JA， Kaufmann H. Epidemiology， diagnosis， and management of neurogenic orthostatic hypotension ［J］. Mov Disord Clin Pract， 2017，4（3）: 298-308.
7	Brignole M， Moya A， de Lange FJ， et al. Practical instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope ［J］.Eur Heart J， 2018， 39（21）: e43-e80.
8	Shaw BH， Garland EM， Black BK， et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a 'sit-to-stand test' ［J］. J Hypertens， 2017， 35（5）: 1019-1025.
9	Rivasi G， Fedorowski A. Hypertension， hypotension and syncope ［J］.Minerva Med， 2022， 113（2）: 251-262.
10	Brignole M， Moya A， de Lange FJ， et al. 2018 ESC guidelines for the diagnosis and management of syncope ［J］. Eur Heart J， 2018， 39（21）:1883-1948.
11	Gibbons CH， Schmidt P， Biaggioni I， et al. The recommendations of a consensus panel for the screening， diagnosis， and treatment of neurogenic orthostatic hypotension and associated supine hypertension ［J］.J Neurol， 2017， 264（8）: 1567-1582.
12	Okamoto LE， Diedrich A， Baudenbacher FJ， et al. Efficacy of servocontrolled splanchnic venous compression in the treatment of orthostatic hypotension: a randomized comparison with midodrine ［J］.Hypertension， 2016， 68（2）: 418-426.
13	Parsaik AK， Singh B， Altayar O， et al. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials ［J］.J Gen Intern Med， 2013， 28（11）: 1496-1503.
14	Schreglmann SR， Büchele F， Sommerauer M， et al. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease- arandomized controlled trial ［J］.Eur J Neurol， 2017， 24（4）: 545-551.
15	Shibao C， Lipsitz LA， Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension ［J］. J Clin Hypertens （Greenwich），2013， 15（3）: 147-153.
16	Singer W， Sandroni P， Opfer-Gehrking TL， et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension ［J］. Arch Neurol，2006， 63（4）: 513-518.
17	Ramirez CE， Okamoto LE， Arnold AC， et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure ［J］. Hypertension， 2014， 64（6）: 1235-1240.
18	Zhang J， Guo L. Effectiveness of acarbose in treating elderly patients with diabetes with postprandial hypotension ［J］. J Investig Med， 2017，65（4）: 772-783.
19	Hauser RA， Isaacson S， Lisk JP， et al. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease （nOH306B）［J］. Mov Disord， 2015， 30（5）: 646-654.
20	Palma JA， Kaufmann H. Management of orthostatic hypotension ［J］.Continuum （Minneap Minn）， 2020， 26（1）: 154-177.
21	Elgebaly A， Abdelazeim B， Mattar O， et al. Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension ［J］.Clin Auton Res， 2016， 26（3）: 171-180.
22	中国老年保健医学研究会晕厥分会，中国康复医学会心血管疾病预防与康复专业委员会. 非心原性晕厥康复中国专家共识［J］. 中国循环杂志， 2023， 38（11）: 1103-1111.

[1]	韩思梁, 孔繁昌, 张兰芳, 赵艳莎, 解俊敏. 罕见晕厥2例及文献复习[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 159-161.
[2]	罗立宏. 中西医结合治疗老年血管迷走神经性晕厥疗效分析[J]. 中华老年病研究电子杂志, 2018, 05(02): 37-40.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Emphasizing to the diagnosis and treatment of orthostatic hypotension

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Emphasizing to the diagnosis and treatment of orthostatic hypotension